Clinical Trial Update: Safety of a New Type of Treatment Called Gene Transfer for the Treatment of Severe Hemophilia B [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update discusses a Phase 1/2 gene transfer therapy being studied for severe Hemophilia B. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Gene Transfer Therapy for Hemophilia B

Snippet

Sponsor: Avigen | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: TERMINATED